Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125525463 | 12552546 | 3 | F | 20160825 | 20160713 | 20160831 | PER | US-PFIZER INC-2016341486 | PFIZER | 46.00 | YR | F | Y | 124.00000 | KG | 20160831 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125525463 | 12552546 | 1 | PS | GENOTROPIN | SOMATROPIN | 1 | Subcutaneous | 0.6 MG, 1X/DAY (EVERY NIGHT) | U | M83322 | 20280 | .6 | MG | POWDER FOR SOLUTION FOR INJECTION | QD | ||||
| 125525463 | 12552546 | 2 | SS | GENOTROPIN | SOMATROPIN | 1 | Subcutaneous | 10 MG, UNK | U | 20280 | 10 | MG | POWDER FOR SOLUTION FOR INJECTION | ||||||
| 125525463 | 12552546 | 3 | SS | GENOTROPIN | SOMATROPIN | 1 | Subcutaneous | 0.4 MG, DAILY | U | M83322 | 20280 | .4 | MG | POWDER FOR SOLUTION FOR INJECTION | |||||
| 125525463 | 12552546 | 4 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 40 MG, 1X/DAY | 0 | 40 | MG | QD | |||||||
| 125525463 | 12552546 | 5 | C | THYROXINE | LEVOTHYROXINE | 1 | Oral | 112.5 UG, 1X/DAY | 0 | 112.5 | UG | QD | |||||||
| 125525463 | 12552546 | 6 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 20 MG, 1X/DAY | 0 | 20 | MG | QD | |||||||
| 125525463 | 12552546 | 7 | C | LASIX | FUROSEMIDE | 1 | Oral | 40 MG, 1X/DAY | 0 | 40 | MG | QD | |||||||
| 125525463 | 12552546 | 8 | C | ESTRADIOL. | ESTRADIOL | 1 | Oral | 1 MG, 1X/DAY | 0 | 1 | MG | QD | |||||||
| 125525463 | 12552546 | 9 | C | VITAMIN D /00107901/ | ERGOCALCIFEROL | 1 | Oral | 2000 IU, 1X/DAY | 0 | 2000 | IU | QD | |||||||
| 125525463 | 12552546 | 10 | C | RANITIDINE. | RANITIDINE | 1 | Oral | 150 MG, 1X/DAY | 0 | 150 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125525463 | 12552546 | 1 | Hypopituitarism |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125525463 | 12552546 | Accidental overdose | |
| 125525463 | 12552546 | Chest pain | |
| 125525463 | 12552546 | Constipation | |
| 125525463 | 12552546 | Head discomfort | |
| 125525463 | 12552546 | Headache | |
| 125525463 | 12552546 | Insomnia | |
| 125525463 | 12552546 | Palpitations | |
| 125525463 | 12552546 | Product quality issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125525463 | 12552546 | 3 | 20160503 | 0 |